Skip to content
Search
AI Powered
Latest Stories

Nicotine alternatives may be more potent than nicotine, US regulator says

Nicotine alternatives may be more potent than nicotine, US regulator says
Anes Saleh, owner of Sultans' Smoke, takes a package of the Spree Bar, which contains a new chemical that mimics nicotine, from the shelf of his store in Arvada, Colorado, U.S., May 21, 2024. REUTERS/Kevin Mohatt
REUTERS

Nicotine alternatives used in vapes being launched in the US and abroad, such as 6-methyl nicotine, may be more potent and addictive than nicotine itself, though the scientific data remains incomplete, according to the US Food and Drug Administration (FDA) and independent researchers.

The synthetic substances - which have a chemical structure similar to that of nicotine - are not subject to US tobacco and vaping regulations that are designed to control traditional nicotine, a highly addictive drug.


That means manufacturers can sell vapes containing synthetic nicotine analogues such as 6-methyl nicotine in the US without seeking authorisation from the FDA - a process that can be costly, time-consuming and is often unsuccessful.

Big tobacco firms like Altria Group and British American Tobacco have already lost substantial US sales to an influx of disposable vapes containing traditional nicotine that are being illegally sold without FDA authorisation.

Altria, the maker of Marlboro cigarettes in the US, highlighted the emerging use of 6-methyl nicotine in vapes and other smoking alternatives in a May 9 letter to the FDA, according to a copy of the correspondence posted on its website.

It urged the agency to evaluate the compounds and establish what authority it had over them, warning they posed a "new threat" to regulation of the sector.

"The introduction and growth of chemicals intended to imitate the effects of nicotine, if left unchecked, could present unknown risks to US consumers and undermine FDA’s authority," the letter said.

It cited Spree Bar, a vape launched in October by Charlie's Holdings Inc that uses 6-methyl nicotine.

The FDA does not comment on its correspondence with individual firms.

In response to Reuters' questions about 6-methyl nicotine and other nicotine alternatives, the FDA said in a statement: "Although more research is needed, some emerging data show these nicotine analogs may be more potent than nicotine – which is already highly addictive, can alter adolescent brain development and have long-term effects on youth's attention, learning and memory."

2024 05 29T113305Z 1387500295 RC2BV7AFI2WT RTRMADP 3 NICOTINE COPYCATThe label on a Spree Bar package provides a brief description of Metatine, a new chemical meant to mimic the effects of nicotine but does not contain nicotine in Denver, Colorado, U.S., May 21, 2024. REUTERS/Kevin Mohatt

Traditional nicotine found in many vapes and pouches is extracted from tobacco leaves. 6-methyl nicotine, in contrast, is made entirely in the lab using chemicals.

The FDA said it was considering the use of such synthetic compounds from an "agency-wide perspective" and would use all of its resources to protect youth from products that may harm their health. As well as tobacco products, the FDA also regulates drugs, foods, cosmetics and more to ensure safety and efficacy.

"The FDA is a data-driven agency, and we're in the process of reviewing the available data to inform potential actions in this space," it said in response to Reuters' questions.

Three academic researchers told the news agency that current studies of 6-methyl nicotine are too limited to draw definite conclusions on the health impact or to what degree it is addictive.

Imad Damaj, a professor in the Department of Pharmacology and Toxicology at Virginia Commonwealth University, said his research showed 6-methyl nicotine may be more potent than nicotine, but more extensive tests were needed to say what impact it has on humans.

The limitations of existing research included that some papers were industry funded, while others focused on the short-term impact on animals or cells and were insufficient to understand 6-methyl nicotine's effects on human bodies, the researchers said.

Charlie's Holdings calls the 6-methyl nicotine solution used in Spree Bar Metatine. SPREE BAR's website says Metatine "may have a toxicity profile similar to nicotine".

Charlie's Holdings co-founder Ryan Stump acknowledged that more research is needed on 6-methyl nicotine, adding that the company dilutes it in its products.

Spree Bar promises users 6,000 puffs from each device and offers fruity flavours including "blue razz ice" and "creamy melon", according to its website.

The FDA has yet to approve any flavoured vape using traditional nicotine for sale in the US, saying companies have not been able to show that the health benefits they offer to smokers outweigh the known risks to young people, who may be more attracted by the flavours.

Stump told Reuters that the company only targets adults, adding that flavours played an important role in its mission to help smokers quit cigarettes. He said Charlie's Holdings respects and abides by laws in every market where it operates.

Stump said that Charlie's Holdings is working on new varieties of Spree Bar and new products using 6-methyl nicotine. It will launch Spree Bar internationally this year. He declined to say where.

The company buys the 6-methyl nicotine solution used in Spree Bar from another US firm, Novel Compounds, according to Novel Compounds' founder Samuel Benaim.

Novel Compounds imports 6-methyl nicotine from overseas and alters it to make it easier for manufacturers like Charlie's Holdings to use in their products. It sells this solution under the trade name imotine.

Tests commissioned by Novel Compounds have found 6-methyl nicotine to be no more harmful than nicotine, Benaim said. But he also said that more research was needed into the chemical.

Benaim added that Novel Compounds had received legal advice that its product is not classified as a tobacco product or drug in the US. The company is committed to legal compliance, he said.

More potent than nicotine?

Sven Jordt, a professor at Duke University, who has authored papers on products like Spree Bar, said 6-methyl nicotine could be more addictive and toxic than its traditional cousin.

"Do we want to have such a chemical as a recreational product, available to anyone?," he asked. "That's really questionable."

Neither Jordt nor Damaj - the professor at Virginia Commonwealth University - have received funding from tobacco or vape makers.

As well as the US, Novel Compounds also sells its 6-methyl nicotine solution around the world, including in the UK, Indonesia, India and Japan.

Another company, Aroma King, sells 6-methyl nicotine in the UK in pouches, which users insert under the lip to get a buzz. The pouches are sold in cans emblazoned with graphics of gorillas in suits and sunglasses.

It said in a February blog post that its 6-methyl nicotine products were "less toxic", "less harmful", and "less addictive" than regular nicotine products.

In a statement to Reuters, Aroma King cited existing research, its own toxicology and other tests and its supplier, which classifies 6-methyl nicotine as less toxic under the European Union's Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation.

Aroma King said 6-methyl nicotine was self-classified by its supplier. It declined to say who supplies it with the chemical.

Four Chinese companies hold patents in China related to the production of 6-methyl nicotine, including Zinwi Biotech, a company that makes the liquid used in vapes.

Zinwi Biotech confirmed it is researching 6-methyl nicotine but did not answer further questions, including on whether it has sold any 6-methyl nicotine so far. Reuters was unable to find contact details for the other firms.

(Reuters)

More for you

Volumatic welcomes new FCA rules safeguarding access to cash

Volumatic welcomes new FCA rules safeguarding access to cash

As industry leaders is cash handling, Volumatic has long supported the use of cash and the importance of maintaining access to cash for both consumers and businesses. The company recognises the importance of the new set of rules created by the Financial Conduct Authority (FCA) two months ago, to safeguard access to cash for businesses and consumers across the UK.

Since introduction, the new rules are intended to ensure that individuals and businesses who rely on cash can continue to access it and the outcome has already sparked the creation of 15 new banking hubs across the UK, including one in Scotland, with many more to follow.

Keep ReadingShow less
Jisp unveils new NPD service

Jisp unveils new NPD service

Retail technology company Jisp has launched an NPD service as part of its new Direct to Retailer business unit.

The new NPD service will allow brands to launch or trial new products in a guaranteed number of convenience store locations, with on the ground review of execution by Jisp’s retail growth manager team, and performance data and insights deliverable through its scanning technology and back-office systems.

Keep ReadingShow less
Tesco launches price cuts in Express convenience stores
File image of Tesco Express

Tesco launches price cuts in Express convenience stores

Tesco is slashing the price of more than 222 own-brand and branded products in its Express convenience stores.

Essentials including milk, bread, pasta and coffee are included in the lines which have been reduced in price by an average of more than 10 per cent at Tesco Express stores. The retail giant has made more than 2,800 price cuts across stores in recent months. With 2,048 of convenience stores at the end of the 2023-24 financial year, Tesco aims to benefit hundreds of thousands of customers from the cheaper deals.

Keep ReadingShow less
vape and cigarette
Photo: iStock

One in five ex-smokers in England now vape, study finds


Summary
1. One in five people who have successfully quit smoking in England currently vape, with an estimated 2.2 million individuals using e-cigarettes as a smoking cessation tool.
2. The increase in vaping among ex-smokers is largely driven by the use of e-cigarettes in quit attempts, with a rise in vaping uptake among people who had previously quit smoking for many years before taking up vaping.
3. While vaping may be a less harmful option compared to smoking, there are concerns about the potential long-term implications of vaping on relapse risk and nicotine addiction. Further research is needed to assess the impact of vaping on smoking cessation outcomes.


Keep ReadingShow less
Bira engages with Treasury on Budget fallout, business rate reform
(Photo by Christopher Furlong/Getty Images)
Getty Images

Bira engages with Treasury on Budget fallout, business rate reform

Independent retailers association Bira has held a meeting with members of the Treasury team to discuss concerns following its robust response to the Government’s recent Budget announcement.

The Budget, labelled by Bira as "devastating" for independent retailers, was met with widespread indignation from Bira members.

Keep ReadingShow less